Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis, JT Knezevich, RM Teply - … Pharmacology: Advances and …, 2013 - Taylor & Francis
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

[PDF][PDF] Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis - 2013 - pdfs.semanticscholar.org
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor.

EM Davis, JT Knezevich, RM Teply - … Pharmacology: Advances and …, 2013 - europepmc.org
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis, JT Knezevich, RM Teply - Clinical Pharmacology: Advances …, 2013 - go.gale.com
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis, JT Knezevich… - Clinical pharmacology …, 2013 - pubmed.ncbi.nlm.nih.gov
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

[HTML][HTML] Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis, JT Knezevich, RM Teply - … Pharmacology: Advances and …, 2013 - ncbi.nlm.nih.gov
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

[PDF][PDF] Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis - 2013 - researchgate.net
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis, JT Knezevich, RM Teply - … Pharmacology: Advances and …, 2013 - dovepress.com
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

[PDF][PDF] Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis - 2013 - Citeseer
Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic
cardiac complications in patients with acute coronary syndrome. Treatment guidelines for …

[引用][C] Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

EM Davis, JT Knezevich… - Clinical …, 2013 - researchworks.creighton.edu